Riskpilot← Back to searchSign inGet full accessAPOTEKET STRØMSØ AS
ASActiveOrg 920990088Blichs Gate 3, 3044 DrammenRetail sale of pharmaceutical products · NACE 4773Est. 20185 employees
Revenue 2024
NOK 22,1M
+9% vs 2023
EBITDA margin
1.8%
-55% vs 2023
Equity ratio
26.0%
Financial strength
Net profit 2024
NOK 189K
-66% vs 2023
| Revenue | NOK 22,1M | +9% |
| EBITDA | NOK 392K | -55% |
| Net profit | NOK 189K | -66% |
| Total assets | NOK 5,4M | -6% |
| Equity | NOK 1,4M | +15% |
| Employees | 5 | — |
Legal name
APOTEKET STRØMSØ AS
Org number
920990088
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
13. juni 2018
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Drive apotek, utleie av apoteks personal, salg av helseprodukter, organiske, økologiske produkter, konsulentvirksomhet, kurs og annet som naturlig faller sammen med dette som at delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Blichs Gate 3, 3044 Drammen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 578 | 16 686 | 18 077 | 20 225 | 22 104 |
| Staff expenses | −2 694 | −2 753 | −2 757 | −2 971 | −3 503 |
| EBITDA | 725 | 496 | 527 | 875 | 392 |
| Depreciation & amort. | −137 | −144 | −149 | −149 | −140 |
| EBIT | 588 | 352 | 377 | 726 | 252 |
| Net financials | 1 | −0 | −0 | 4 | 4 |
| Profit before tax | 589 | 352 | 377 | 730 | 256 |
| Tax | 18 | 77 | 83 | 169 | 67 |
| Net profit | 571 | 275 | 294 | 561 | 189 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 338 | 4 071 | 4 205 | 5 809 | 5 442 |
| Equity | 94 | 369 | 663 | 1 224 | 1 413 |
| Long-term debt | 1 456 | 1 453 | 1 442 | 1 440 | 1 440 |
| Short-term debt | 1 787 | 2 249 | 2 100 | 3 145 | 2 588 |
| Total debt | 3 244 | 3 702 | 3 542 | 4 585 | 4 028 |
EBITDA margin
1.8%
This company
15.8%
Market median
-89% vs market
20202024
Equity ratio
26.0%
This company
38.2%
Market median
-32% vs market
20202024
Return on equity
13.4%
This company
18.4%
Market median
+27% vs market
20202024
Net profit margin
0.9%
This company
8.1%
Market median
-89% vs market
20202024
Asset turnover
4.06×
This company
1.12×
Market median
+262% vs market
20202024
Debt / equity
2.85×
This company
0.62×
Market median
-360% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AA Chief Executive Officer | Chief Executive Officer | 2018 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Arvans Holdingselskap As
APOTEKET STRØMSØ AS Board members of APOTEKET STRØMSØ AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Amir Arvan | Chief Executive Officer | 0 companies |